RDIF and CDC IC announce the expansion of investment cooperation

Press release, 19.12.2017

Moscow, 19 December, 2017 - The Russian Direct Investment Fund (RDIF) and CDC International Capital (CDC IC) announce an expansion in the scope of cooperation within the framework of the Russia-France investment platform. The parties have agreed to jointly search and invest into small and medium-sized businesses in both Russia and France (standard investment amount in each project below 20 million euros). These investments will strengthen trade and economic cooperation between the two countries. A corresponding agreement was signed today in the presence of the French Economy and Finance Minister Bruno Le Maire and the Russian Minister of Economic Development Maxim Oreshkin, during the 23rd session of the Russian-French Council for Economic, Financial, Industrial and Commercial Cooperation (CEFIC).

Further to this agreement, the parties are considering the first transaction of the expanded partnership, an investment in the French biotechnology group Olmix. Olmix is a specialist in the production of natural algae products for nutrition, hygiene, and human, animal, and plant health. Investment of up to 15 million euros, will be used to expand the production facilities of Olmix Group in St. Petersburg. This will allow Olmix Group to expand its range of available products and its presence in Russian and CIS markets.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said:
"We welcome the expanded scope of cooperation with our French partner CDC IC, aimed at identifying attractive investment opportunities in small and medium-sized companies. Biotechnology company Olmix, which plans to expand its presence in Russia, is the first potential opportunity of that kind. We believe that Russian-French cooperation has great potential and are already looking into additional opportunities that will facilitate Russian and French companies entering the markets of both countries."

Laurent Vigier, CEO of CDC International Capital (CDC IC), stated:
"We look forward to further develop our historical relationship with RDIF. The updated framework underlines once more our joint commitment to facilitate the development of French companies in Russia. Extension of our collaboration equally signals a mutual willingness to support Russian companies expanding in the French market. We welcome cooperation with Olmix Group, an innovative French company in the agribusiness sector. The Group’s plans expansion of its activity in a very promising region - Russia and the CIS - while also strengthening its territorial positioning in Brittany, where the group was founded."

Hervé Balusson, President of Olmix Group, concluded:
"Potential partnership with CDC IC and RDIF represents a major opportunity for Olmix Group and it is an important sign of interest in our no-pesticide and -antibiotic solutions as well as our Aroma Health products."

***

Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Further information can be found at www.rdif.ru

CDC International Capital is a subsidiary of Caisse des Dépôts which is dedicated to direct investments alongside sovereign funds and other large international institutional players. CDC Capital International is also involved in various asset classes that meet the needs of the French economy and the expectations of its partners. Using these vehicles, CDC International Capital manages the capital share of Caisse des Dépôts and is responsible for the selection and monitoring of its investments alongside its partners. For more information about CDC International Capital please visit http://www.cdcicapital.fr

Olmix Group - founded in 1995, Olmix Group is an innovative medium-sized company and a leader in the marine biotechnology space. It has developed complementary business lines in the following areas:

  • Animal Care is a division focused on solutions around well-being, health and animal nutrition. It aims to reduce the use of antibiotics, decreasing mycotoxin risk and improve digestive efficiency/welfare and immunity for animals
  • Plant Care is a division focused on providing organic plant nutrition solutions to improve soil life activation, soil fertilization, plant health optimization, etc.
  • Human Care is a division offering solutions to improve human health by replacing additives, preservatives, emulsifiers and thickeners through algae-based natural ingredients


The group aims to generate over 150 million Euros in revenues by 31st December 2017. It has offices in 25 countries and distributes its products in over 100 countries with strong estimated growth over each continent. For more information about Olmix Group please visit https://www.olmix.com/fr/amadeite

For additional information contact:
Arseniy Palagin
Russian Direct Investment Fund
Press Secretary
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41
E-mail: arseniy.palagin@rdif.ru

Andrew Hayes / Elena Garside
Hudson Sandler
Tel: +44 (0) 20 7796 4133

Olmix Group
Aurélie Garel

E-mail: agaerl@olmix.com
Tel: +33(0)6 45 59 52 37

Steele&Holt (CDC International Capital)
Daphné Claude
E-mail: daphne@steeleandholt.com
Tel: +33 6 66 58 81 92

Dominic Riding
E-mail: dominic@steeleandholt.com
Tel: +33 6 48 57 83 24